Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: An optical coherence tomography study

International Journal of Cardiology

Volumn 151, Issue 2, 2011, Pages 155-159

  Davlouros, Periklis A ^a   Nikokiris, George ^a   Karantalis, Vasileios ^a   Mavronasiou, Eleni ^a   Xanthopoulou, Ioanna ^a   Damelou, Anastasia ^a   Tsigkas, Grigorios ^a   Alexopoulos, Dimitrios ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Malapposition; Neointima; OCT; Paclitaxel

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PACLITAXEL;

ACUTE CORONARY SYNDROME; ADULT; ANALYSIS OF COVARIANCE; ARTERY INTIMA; ARTICLE; CLINICAL ARTICLE; COMPLICATION; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTRACARDIAC THROMBOSIS; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REGRESSION ANALYSIS; STRUT MALAPPOSITION; STRUT PROTRUSION; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOINTIMA; PACLITAXEL; PROGNOSIS; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TUNICA INTIMA;

EID: 80052329078     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.05.004     Document Type: Article

References (30)

1. M.N. Babapulle, L. Joseph, and P. Belisle A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents Lancet 364 2004 583 591 (Pubitemid 39094175)
2. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents Jama 293 2005 2126 2130 (Pubitemid 40617065)
3. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
4. A.V. Finn, M. Joner, and G. Nakazawa Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization Circulation 115 2007 2435 2441 (Pubitemid 46717966)
5. S. Cook, E. Ladich, and G. Nakazawa Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis Circulation 120 2009 391 399
6. I.K. Jang, B.E. Bouma, and D.H. Kang Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound J Am Coll Cardiol 39 2002 604 609 (Pubitemid 34158155)
7. K. Ishigami, S. Uemura, and Y. Morikawa Long-term follow-up of neointimal coverage of sirolimus-eluting stents-evaluation with optical coherence tomography Circ J 73 2009 2300 2307
8. F. Tian, Y.D. Chen, and Z.J. Sun Evaluation of neointimal coverage of overlapping sirolimus-eluting stents by optical coherence tomography Chin Med J 122 2009 670 674
9. J.S. Kim, C. Fan, and D. Choi Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study Int J Cardiol 2009 [Aug 24, Electronic publication ahead of print]
10. J. Tanigawa, P. Barlis, and K. Dimopoulos The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography Int J Cardiol 134 2009 180 188
11. P. Motreff, G. Souteyrand, and S. Levesque Comparative analysis of neointimal coverage with paclitaxel and zotarolimus drug-eluting stents, using optical coherence tomography 6 months after implantation Arch Cardiovasc Dis 102 2009 617 624
12. P. Moore, P. Barlis, and J. Spiro A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents Jacc 2 2009 437 444
13. N. Gonzalo, H.M. Garcia-Garcia, and P.W. Serruys Reproducibility of quantitative optical coherence tomography for stent analysis EuroIntervention 5 2009 224 232
14. P. Barlis, K. Dimopoulos, and J. Tanigawa Quantitative analysis of intracoronary optical coherence tomography measurements of stent strut apposition and tissue coverage Int J Cardiol 141 2 2009 151 156
15. Z.H. Yao, T. Matsubara, and T. Inada Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography Chin Med J 121 2008 503 507 (Pubitemid 351479628)
16. Y. Xie, M. Takano, and D. Murakami Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation Am J Cardiol 102 2008 27 31
17. B.X. Chen, F.Y. Ma, and W. Luo Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography Heart (British Cardiac Society) 94 2008 566 570 (Pubitemid 351580126)
18. M. Takano, S. Inami, and I.K. Jang Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation Am J Cardiol 99 2007 1033 1038 (Pubitemid 46560470)
19. D. Matsumoto, J. Shite, and T. Shinke Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography Eur Heart J 28 2007 961 967 (Pubitemid 47343895)
20. I.K. Jang, G.J. Tearney, and B. MacNeill In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography Circulation 111 2005 1551 1555 (Pubitemid 40470652)
21. P.A. Lemos, B. Moulin, and M.A. Perin Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial Catheter Cardiovasc Interv 74 5 2009 665 673
22. C.U. Choi, S.W. Rha, and K.Y. Chen Lack of clinical benefit of improved angiographic results with sirolimus-eluting stents compared with paclitaxel and zotarolimus-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention Circ J 73 2009 2229 2235
23. G.J. Wilson, G. Nakazawa, and R.S. Schwartz Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries Circulation 120 141-9 2009 1 2
24. S. Cook, P. Wenaweser, and M. Togni Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation Circulation 115 2007 2426 2434 (Pubitemid 46717965)
25. T.F. Luscher, J. Steffel, and F.R. Eberli Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications Circulation 115 2007 1051 1058 (Pubitemid 46328299)
26. G.S. Mintz What to do about late incomplete stent apposition? Circulation 115 2007 2379 2381 (Pubitemid 46717959)
27. V.M. Shah, G.S. Mintz, and S. Apple Background incidence of late malapposition after bare-metal stent implantation Circulation 106 2002 1753 1755
28. M.K. Hong, G.S. Mintz, and C.W. Lee Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up Circulation 113 2006 414 419 (Pubitemid 43803203)
29. K. Tanabe, P.W. Serruys, and M. Degertekin Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial Circulation 111 2005 900 905 (Pubitemid 40279892)
30. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150